作者
L Graat-Verboom, EFM Wouters, FWJM Smeenk, BEEM Van Den Borne, R Lunde, MA Spruit
发表日期
2009/7/1
来源
European Respiratory Journal
卷号
34
期号
1
页码范围
209-218
出版商
European Respiratory Society
简介
Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of osteoporosis. However, the prevalence, correlates and effectiveness of treatment of osteoporosis in COPD patients remain unclear.
We performed a systematic review of the literature to answer three questions. 1) What is the prevalence of osteoporosis in COPD? 2) What are identified correlates of osteoporosis in COPD? 3) What are the effects of treatment of osteoporosis in COPD? A computerised literature search in MEDLINE/PubMed and the Cochrane database was carried out. In addition, reference lists were searched by hand and authors were contacted if necessary.
The prevalence of osteoporosis and osteopenia varied 9–69% and 27–67%, respectively. Prevalence of osteoporosis was generally higher than in healthy subjects and some other chronic lung diseases. Correlates of osteoporosis in COPD are mainly …
引用总数
20092010201120122013201420152016201720182019202020212022202320245172025293642343529283120192111
学术搜索中的文章
L Graat-Verboom, EFM Wouters, F Smeenk… - European Respiratory Journal, 2009